Vanda Pharmaceuticals | VNDA - EPS Earnings Per Share


Vanda Pharmaceuticals reported $-0.09 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
AstraZeneca USD 2.58 0.46 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
Merck USD -1.28 3.32 Mar/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Moderna USD -3.4 1.29 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.88 0.35 Mar/2026
Takeda JPY 65.74 73.57 Dec/2025
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Veracyte USD 0.52 0.01 Mar/2026